Epigral officials to speak at Anand Rathi G-200 Summit in Mumbai

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Epigral Limited officials to attend Anand Rathi G-200 Summit 2026
  • Event scheduled for September 21, 2026, in Mumbai
  • Company confirms no unpublished price-sensitive info will be shared
  • Disclosure made under SEBI LODR Regulation 30
powered bylight_fuzz_icon
51107647

*this image is generated using AI for illustrative purposes only.

Epigral Limited has confirmed that its officials will participate in the Anand Rathi Annual Flagship Conference: G-200 Summit 2026. The event is scheduled for Monday, September 21, 2026, in Mumbai.

The disclosure was made pursuant to Regulation 30 and Para (A) of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that no unpublished price-sensitive information will be shared or discussed during these interactions.

Conference Details

Parameter Details
Event Name Anand Rathi Annual Flagship Conference: G-200 Summit 2026
Date September 21, 2026
Location Mumbai

The schedule for participation is subject to change due to exigencies, if any. Maulik Patel, Chairman and Managing Director of Epigral Limited , signed the intimation letter dated September 16, 2026.

Historical Stock Returns for Epigral

1 Day5 Days1 Month6 Months1 Year5 Years
-2.99%-10.19%-20.33%+21.19%-41.92%+26.21%

How might Epigral's participation in the G-200 Summit influence investor sentiment and short-term stock volatility?

What specific strategic initiatives or growth verticals is Epigral likely to highlight to institutional investors during this flagship event?

Could this conference serve as a catalyst for Epigral to announce new partnerships or expansion plans in the near future?

Epigral to host Bellwether Capital for plant visit in Gujarat

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Epigral Limited hosts Bellwether Capital for a plant visit
  • Engagement scheduled for September 3, 2026
  • Location is the manufacturing facility in Dahej, Gujarat
  • No unpublished price-sensitive information to be shared
powered bylight_fuzz_icon
49728468

*this image is generated using AI for illustrative purposes only.

Epigral Limited has scheduled an investor and analyst plant visit for September 3, 2026. The company will host representatives from Bellwether Capital at its manufacturing facility in Dahej, Gujarat.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Epigral informed the National Stock Exchange of India Limited and BSE Limited on August 31, 2026, regarding the upcoming engagement.

Visit Details

The plant visit is planned for Thursday, September 3, 2026. The location is the Dahej unit in Gujarat. The mode of interaction is an in-person plant visit.

Detail Information
Investor/Analyst Bellwether Capital
Date September 3, 2026
Location Dahej, Gujarat
Mode Plant Visit

Regulatory Disclosures

Epigral stated that the schedule is subject to change due to exigencies on the part of the analyst, investor, or the company. The firm emphasized that no unpublished price-sensitive information will be shared or discussed during the visit.

Gaurang Trivedi, Company Secretary and Compliance Officer, signed the intimation filed with the exchanges.

Historical Stock Returns for Epigral

1 Day5 Days1 Month6 Months1 Year5 Years
-2.99%-10.19%-20.33%+21.19%-41.92%+26.21%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

What specific operational metrics or capacity expansion plans at the Dahej facility is Bellwether Capital likely focusing on during this visit?

How might insights from this engagement influence Epigral's valuation multiples in the near term compared to its peers?

Could this targeted investor outreach signal upcoming strategic initiatives, such as new product launches or M&A activity, for Epigral?

More News on Epigral

1 Year Returns:-41.92%